What are the essential aspects of transcatheter LAA closure?
Description
In this #europcr 2025 exchange, Ole De Backer and Philippe Garot explore the evolving landscape of transcatheter left atrial appendage (LAA) occlusion.
From differences in patient selection on either side of the Atlantic—high bleeding risk in Europe vs. broader indications in the US—to upcoming pivotal trials comparing LAA closure to DOACs, this conversation covers it all.
They also break down what defines a state-of-the-art LAA procedure, with an emphasis on pre-procedural imaging (cardiac CT or 3D TEE), and share key insights on post-procedural management, including antithrombotic therapy and follow-up imaging.
Hit play for a quick yet comprehensive update on where LAA closure is headed.
Hosted on Acast. See acast.com/privacy for more information.
United States
